|
US2006099608A1
|
|
Methods of diagnosing cardiovascular disease
|
|
CA2509098A1
|
|
Identification of genes involved in angiogenesis, and development of an angiogenesis diagnostic chip to identify patients with impaired angiogenesis
|
|
WO03064663A1
|
|
Polymorphisms in elastin, fibrillin, and related genes as predisposing to restenosis and to atherosclerosis
|
|
WO03039349A2
|
|
Method of using physiological markers to estimate cardiovascular risk
|
|
AU2002332122A1
|
|
Modulation of akt-dependent response to prevent restenosis
|
|
CN1599799A
|
|
Identification of genes involved in restenosis and in atherosclerosis
|
|
WO02087472A1
|
|
Stent-based delivery of statins to prevent restenosis
|
|
EP1365754A2
|
|
Inhibition of proteasomes to prevent restenosis
|
|
WO02059261A2
|
|
Inhibition of restenosis using a dna-coated stent
|
|
EP1146891A1
|
|
Therapy of restenosis and atherosclerosis with a soluble vegf receptor and angiopoeitin-1
|
